Literature DB >> 12773772

Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.

Christopher Lau1, Julie R Thibodeaux, Roger G Hanson, John M Rogers, Brian E Grey, Mark E Stanton, John L Butenhoff, Lisa A Stevenson.   

Abstract

The postnatal effects of in utero exposure to perfluorooctane sulfonate (PFOS, C8F17SO3-) were evaluated in the rat and mouse. Pregnant Sprague-Dawley rats were given 1, 2, 3, 5, or 10 mg/kg PFOS daily by gavage from gestation day (GD) 2 to GD 21; pregnant CD-1 mice were treated with 1, 5, 10, 15, and 20 mg/kg PFOS from GD 1 to GD 18. Controls received 0.5% Tween-20 vehicle (1 ml/kg for rats and 10 ml/kg for mice). At parturition, newborns were observed for clinical signs and survival. All animals were born alive and initially appeared to be active. In the highest dosage groups (10 mg/kg for rat and 20 mg/kg for mouse), the neonates became pale, inactive, and moribund within 30-60 min, and all died soon afterward. In the 5 mg/kg (rat) and 15 mg/kg (mouse) dosage groups, the neonates also became moribund but survived for a longer period of time (8-12 h). Over 95% of these animals died within 24 h. Approximately 50% of offspring died at 3 mg/kg for rat and 10 mg/kg for mouse. Cross-fostering the PFOS-exposed rat neonates (5 mg/kg) to control nursing dams failed to improve survival. Serum concentrations of PFOS in newborn rats mirrored the maternal administered dosage and were similar to those in the maternal circulation at GD 21; PFOS levels in the surviving neonates declined in the ensuing days. Small but significant and persistent growth lags were detected in surviving rat and mouse pups exposed to PFOS prenatally, and slight delays in eye opening were noted. Significant increases in liver weight were observed in the PFOS-exposed mouse pups. Serum thyroxine levels were suppressed in the PFOS-treated rat pups, although triiodothyronine and thyroid-stimulating hormone [TSH] levels were not altered. Choline acetyltransferase activity (an enzyme that is sensitive to thyroid status) in the prefrontal cortex of rat pups exposed to PFOS prenatally was slightly reduced, but activity in the hippocampus was not affected. Development of learning, determined by T-maze delayed alternation in weanling rats, was not affected by PFOS exposure. These results indicate that in utero exposure to PFOS severely compromised postnatal survival of neonatal rats and mice, and caused delays in growth and development that were accompanied by hypothyroxinemia in the surviving rat pups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773772     DOI: 10.1093/toxsci/kfg122

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  98 in total

1.  Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.

Authors:  Brianna N VanNoy; Juleen Lam; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2018-06

2.  Characterization of non-radiolabeled Thyroxine (T4) uptake in cryopreserved rat hepatocyte suspensions: Pharmacokinetic implications for PFOA and PFOS chemical exposure.

Authors:  Julian Selano; Vicki Richardson; John Washington; Chris Mazur
Journal:  Toxicol In Vitro       Date:  2019-03-28       Impact factor: 3.500

3.  Levels of perfluorinated compounds in human breast milk in Jordan: the impact of sociodemographic characteristics.

Authors:  Nihaya A Al-sheyab; Khaled M Al-Qudah; Yahya R Tahboub
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-24       Impact factor: 4.223

4.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

5.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

6.  Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS).

Authors:  Haihua Huang; Changjiang Huang; Lijun Wang; Xiaowei Ye; Chenglian Bai; Michael T Simonich; Robert L Tanguay; Qiaoxiang Dong
Journal:  Aquat Toxicol       Date:  2010-02-06       Impact factor: 4.964

7.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.

Authors:  Patricia A Fair; Erin Driscoll; Meagan A M Mollenhauer; Sarah G Bradshaw; Se Hun Yun; Kurunthachalam Kannan; Gregory D Bossart; Deborah E Keil; Margie M Peden-Adams
Journal:  J Immunotoxicol       Date:  2011-01-24       Impact factor: 3.000

8.  PFAS profiles in three North Sea top predators: metabolic differences among species?

Authors:  Anders Galatius; Rossana Bossi; Christian Sonne; Frank Farsø Rigét; Carl Christian Kinze; Christina Lockyer; Jonas Teilmann; Rune Dietz
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-28       Impact factor: 4.223

9.  Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor.

Authors:  Manhai Long; Mandana Ghisari; Eva Cecilie Bonefeld-Jørgensen
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-29       Impact factor: 4.223

10.  Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.

Authors:  Noriaki Washino; Yasuaki Saijo; Seiko Sasaki; Shizue Kato; Susumu Ban; Kanae Konishi; Rie Ito; Ayako Nakata; Yusuke Iwasaki; Koichi Saito; Hiroyuki Nakazawa; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2008-11-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.